Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 7/20 | 0.98 |
| ▸ | BCHE | P06276 | 4/20 | 0.98 |
| ▸ | MEN1 | O00255 | 4/20 | 0.98 |
| ▸ | BLM | P54132 | 4/20 | 0.98 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.98 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.98 |
| ▸ | MAPT | P10636 | 3/20 | 0.98 |
| ▸ | THRB | P10828 | 3/20 | 0.98 |
| ▸ | HPGD | P15428 | 3/20 | 0.98 |
| ▸ | CASP1 | P29466 | 3/20 | 0.98 |
| ▸ | RECQL | P46063 | 3/20 | 0.98 |
| ▸ | CASP7 | P55210 | 3/20 | 0.98 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.98 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.98 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.98 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.98 |
| ▸ | TERT | O14746 | 3/20 | 0.65 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.65 |
| ▸ | MITF | O75030 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL55279 | 0.99 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| SCHEMBL30379131 | 0.99 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Hydrochloric Acid SCHEMBL5482694 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| Iodide SCHEMBL14996 | 0.98 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Iodide SCHEMBL29527724 | 0.98 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Iodide SCHEMBL29351886 | 0.98 | ACHE (1.00) | ACHEBCHEMEN1BLMKMT2A | |
| Bromide SCHEMBL30669741 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| Bromide SCHEMBL290404 | 0.98 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| Water SCHEMBL9106337 | 0.97 | ACHE (0.98) | ACHEBCHEMEN1BLMKMT2A | |
| SCHEMBL3629831 | 0.95 | ACHE (0.92) | ACHEBCHEMEN1BLMKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117160276-A | Rotor for biological reaction | 河络新图生物科技(上海)有限公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-109068628-B | Herbicidal pesticide composition and herbicidal method using the same | 组合化学工业株式会社 | 2021-09-03 | — | — | CN | disclosed |
| CN-113227255-A | Foaming composition, foaming matrix and method | 科发龙技术公司 | 2021-08-06 | — | — | CN | disclosed |
| EP-3100736-A1 | SIRTUIN INDUCER, TISSUE REPAIRING AGENT, HEPATOCYTE GROWTH FACTOR INDUCER, TISSUE HOMEOSTASIS MAINTENANCE AGENT, AND TLR4 AGONIST, HAVING HYALURONIC ACID FRAGMENT AS ACTIVE INGREDIENT | Hyaluronan Research Institute, Inc. (JP) | 2016-12-07 | — | — | EP | disclosed |
| EP-2818172-A1 | TLR4 AGENT, TISSUE HOMEOSTASIS AGENT, HEPATOCYTE GROWTH FACTOR INDUCER, TISSUE REPAIRING AGENT, AND SIRTUIN INDUCER HAVING HYALURONIC ACID FRAGMENTS AS ACTIVE INGREDIENTS THEREOF | Hyaluronan Research Institute, Inc. (JP) | 2014-12-31 | — | — | EP | disclosed |
| US-20110294772-A1 | USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS | UNIVERSITAT DE LES ILLES BALEARS (ES) | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294772-A1 | USE OF CYCLOSQUARAMIDE COMPOUNDS AS ANTI-TUMOUR AGENTS | DCK, DTYMK, TYMS | ACHE 242/4885BCHE 111/4885MEN1 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.